Baird downgraded Gilead Sciences (NASDAQ: GILD) from Outperform to Neutral with a price target of $79.00.Analyst Brian Skorney comments "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE